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Abstract 
Background: The directed differentiation of mesenchymal stem cells (MSCs) is tightly controlled by a complex 
network. Wnt signaling pathways have an important function in controlling the fate of MSCs. However, the mecha-
nism through which Wnt/β-catenin signaling is regulated in differentiation of MSCs remains unknown. SIRT1 plays an 
important role in the regulation of MSCs differentiation.
Results: This study aimed to determine the effect of sirtuin 1 (SIRT1) on adipogenesis and myogenic differentiation 
of C3H10T1/2 cells. First, the MSC commitment and differentiation model was established by using 5-azacytidine. 
Using the established model, C3H10T1/2 cells were treated with SIRT1 activator/inhibitor during differentiation. The 
results showed that resveratrol inhibits adipogenic differentiation and improves myogenic differentiation, whereas 
nicotinamide promotes adipogenic differentiation. Notably, during commitment, resveratrol blocked adipocyte for-
mation and promoted myotubes differentiation, whereas nicotinamide enhanced adipogenic potential of C3H10T1/2 
cells. Furthermore, resveratrol elevated the expression of Cyclin D1 and β-catenin in the early stages. The luciferase 
assay showed that knockdown SIRT1 inhibits Wnt/β-catenin signaling, while resveratrol treatment or overexpression 
SIRT1 activates Wnt/β-catenin signaling. SIRT1 suppressed the expression of Wnt signaling antagonists sFRP2 and 
DACT1. Knockdown SIRT1 promoted adipogenic potential of C3H10T1/2 cells, whereas overexpression SIRT1 inhibited 
adipogenic differentiation and promoted myogenic differentiation.
Conclusions: Together, our results suggested that SIRT1 inhibits adipogenesis and stimulates myogenic differentia-
tion by activating Wnt signaling.
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Background
Mesenchymal stem cells (MSCs) are multipotent stromal 
cells that can differentiate into adipocytes, myoblasts, 
osteoblasts and chondrocytes [1]. When triggered by 
appropriate condition, MSCs become committed to the 
adipocyte lineage. This process can be divided into two 
related stages: commitment and terminal differentiation 
[2, 3]. The differentiation into different cell lineages is 
determined by different factors and signaling pathways. 
Wnt signaling pathways have an important function in 
controlling the fate of MSCs [4]. Canonical β-catenin-
dependent Wnt signaling maintains preadipocytes in an 
undifferentiated state through inhibition of the adipo-
genic transcription factors CCAAT/enhancer binding 
protein α (C/EBPα) and peroxisome proliferator-acti-
vated receptor γ (PPARγ) [5]. Canonical Wnt signalling 
has been implicated in satellite cell-related transdifferen-
tiation and increasing myogenic potential [6]. Wnt sig-
nalling is influenced by potent antagonists, which exert 
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their inhibitory effects at different points of the pathway. 
Although research has demonstrated that Wnt antago-
nists exert a crucial role during the differentiation pro-
cess of preadipocytes into mature fat cells [2], research 
on the commitment process is lacking. Secreted frizzled-
related proteins (sFRPs), extracellular antagonists of Wnt 
signaling, are induced during adipogenesis; constitutive 
overexpression of sFRP1 in  vitro promotes adipogenic 
differentiation through inhibition of canonical Wnt sign-
aling [7]. Dacts, a homologue of Dapper, are antagonist to 
Wnt/β-catenin signaling. Knockdown of Dact1 impairs 
adipogenesis and constitutive overexpression of Dact1 
promotes adipogenesis through inhibition/activation of 
the Wnt/β-catenin signaling [8]. However, the mecha-
nism through which Wnt/β-catenin signaling is regulated 
in controlling the fate of MSCs remains unknown.
Sirtuin 1 (SIRT1) is a nicotinamide adenine dinucleotide-
dependent lysine deacetylase that is involved in controlling 
the expression of key regulators of lifespan, cell defence, 
insulin secretion and adipocyte differentiation and metab-
olism [9–12]. The function of SIRT1 in adipogenesis has 
been reported by some researchers. Studies show that acti-
vation of SIRT1 by resveratrol blocks adipocyte develop-
ment and increases the expression of osteoblast markers, 
whereas inhibition of SIRT1 by nicotinamide increases 
adipocyte number and expression of adipocyte markers 
in C3H10T1/2 [13]. In addition, resveratrol regulates cell 
cycle exit and induces C2C12 cells differentiation, con-
trols muscle-specific proteins synthesis [14]. However, the 
mechanisms of SIRT1 in regulating adipogenesis and myo-
genic differentiation remain unclear. We hypothesize that 
SIRT1 controls adipogenesis and myogenesis of MSCs by 
regulating the Wnt signaling pathway.
C3H10T1/2 stem cell line was originally isolated from 
C3H mouse embryos. It behaves in a manner simi-
lar to that of MSCs, making C3H10T1/2 cells a use-
ful MSC model [15]. Previous research has shown that 
low concentrations of the DNA methylation inhibitor 
5-azacytidine (5-AZA) converts C3H10T1/2 cells into 
differentiated chondrocytes, adipocytes and skeletal 
muscles [16]. 5-AZA is an effective agent for determining 
the fate of MSCs. In the present study, we aimed to inves-
tigate the function of SIRT1 in regulating MSC com-
mitment into the adipogenic lineage. Our findings may 
potentially have a role in fat formation and lead to the 
development of novel therapeutic approaches to human 
obesity-related diseases.
Results
Establishment of the MSC commitment and differentiation 
model
To establish a commitment and differentiation model 
of MSCs, C3H10T1/2 cells were induced with 5, 10, 20 
or 40  µM of 5-AZA for 3 days and cultured in GM for 
another 14 days. Myogenic and adipogenic phenotypes 
were measured by using DiI staining and Oil Red O stain-
ing, respectively. 5-AZA treatment increased myocyte 
formation (Fig. 1a) and lipid accumulation (Fig. 1c) with 
the concentration gradient. Treatment with 20 and 40 µM 
5-AZA effectively induced myocyte and adipocyte for-
mation. Cells cultured in GM were harvested at 0, 3, 7 
and 14 days to determine the mRNA expression profile 
of marker genes for myogenesis and adipogenesis. The 
results showed that the myogenic marker gene MyoD was 
highly expressed at 7 days of inducing differentiation, and 
the late differentiation marker MyHc was highly expressed 
at 14 days of differentiation (Fig. 1b). Meanwhile, the adi-
pogenic markers PPARγ and adiponectin were highly 
expressed at 7 and 14 days of differentiation, respec-
tively (Fig. 1d). The myogenic or adipogenic marker gene 
expressions of 20 and 40 µM 5-AZA-treated groups were 
the highest. The values were significantly higher than the 
5 and 10 µM recorded for 5-AZA-treated cells. The results 
indicated that 20 and 40 µM 5-AZA treatment effectively 
induced MSC commitment to the myocyte and adipocyte 
lineage. Thus, treatment with 20 µM 5-AZA was chosen 
to be used for subsequent study.
Using 20 µM 5-AZA treatment, C3H10T1/2 cells were 
induced for 0, 12, 24, 48, 72 and 96 h. After 8 days of cul-
ture in pre-adipocyte adipogenic cocktail, the cells were 
stained with Oil Red O to measure adipogenic pheno-
type. The results showed that no adipocyte was formed in 
groups treated with 5-AZA for 0, 12 and 24 h. Adipocytes 
were formed by treatment with 5-AZA for more than 
48  h, and adipocyte number increased with treatment 
time (Fig.  2a, b). Through real-time polymerase chain 
reaction (PCR) analyses, we determined that 5-AZA sig-
nificantly induced the mRNA expression of adipogenic 
markers (PPARγ, aP2, and adiponectin) with the increase 
in treatment duration (Fig. 2c). In summary, cells treated 
with 20 µM 5-AZA for 3 days effectively induced the con-
version of MSCs to adipocytes, and will be adopted for 
subsequent study.
Effect of SIRT1 on MSC adipogenic differentiation
To explore the role of SIRT1 in adipogenic differen-
tiation of MSCs, SIRT1 activator (resveratrol)/inhibi-
tor (nicotinamide) was added to GM of C3H10T1/2 
cells after 5-AZA treatment during differentiation, as 
shown in Fig.  3a. First, we explored the effect of SIRT1 
on C3H10T1/2 cell differentiation using Oil Red O stain-
ing for lipid droplets. Oil Red O staining showed that 
compared with the control group, resveratrol inhibited 
the adipogenic differentiation of C3H10T1/2, whereas 
nicotinamide increased the adipogenic differentiation of 
C3H10T1/2 (Fig.  3b, c). The mRNA and protein levels 
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of the adipogenic markers (PPARγ, ap2 and adiponec-
tin) were also slightly reduced in the resveratrol group 
(Fig.  3d, e). By contrast, the mRNA and protein levels 
of the adipogenic marker genes significantly improved 
in the nicotinamide group (Fig.  3d, e). The results sug-
gested that activation of SIRT1 by resveratrol inhibits 
Fig. 1 5-Azacytidine induces C3H10T1/2 cells into differentiated adipocytes and myocytes. C3H10T1/2 cells were treated with 5, 10, 20, and 40 μM 
5-azacytidine for 3 days, then changed GM culture treated for next 14 days. a Cells were fixed and stained with DiI on day 14 days after GM Culture. 
b The relative expression profile of myogenic marker genes: MyoD and MyHc were determined using Real-time PCR at 0, 3, 7, and 14 days after 
treatment. c Oil Red-O staining of cells on day 14 days after GM culture. d The relative expression profile of adipogenic marker genes: PPARγ and adi-
ponentin were determined using Real-time PCR at 0, 3, 7, and 14 days after treatment. The green arrow points to the myotube. The red arrow points 
to the lipid droplet. Data represent mean ± SEM from three independent experiments. *P < 0.05; **P < 0.01
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the adipogenic differentiation of C3H10T1/2, whereas 
inhibition of SIRT1 by nicotinamide promotes the adipo-
genic differentiation of C3H10T1/2. Dil staining showed 
that resveratrol promoted myotubes formation, whereas 
nicotinamide increased the myogenic differentiation 
of C3H10T1/2 (Fig.  3f ). We next examined the mRNA 
levels of myogenic markers MyoD and MyHc during dif-
ferentiation (Fig.  3g), suggesting that resveratrol signifi-
cantly increased myogenic differentiation.
Effect of SIRT1 on MSC adipogenic commitment
Using the established model, MSCs were treated with 
SIRT1 activator/inhibitor during commitment to study 
the effect of SIRT1. To explore the function of SIRT1 in 
C3H10T1/2 committed to the adipocyte lineage, SIRT1 
activator (resveratrol)/inhibitor (nicotinamide) was 
added to C3H10T1/2 cells with 5-AZA during com-
mitment, as shown in Fig.  4a. As shown in Fig.  4b and 
c, Oil Red O staining demonstrated results similar to 
those of differentiation. Compared with the control 
group, resveratrol attenuated C3H10T1/2 cells com-
mitted to the adipocyte lineage, whereas nicotinamide 
increased C3H10T1/2 committed to the adipocyte lin-
eage. The mRNA and protein levels of the adipogenic 
markers were also slightly suppressed in the resvera-
trol group (Fig.  4d, e). By contrast, mRNA and protein 
Fig. 2 5-Azacytidine induces C3H10T1/2 cells into differentiated adipocytes for different treatment time. The C3H10T1/2 cells were induced with 
20 μM 5-azacytidine for 0, 12, 24, 48, 72, and 96 h, then changed adipocyte differentiation medium for 8 days. a After 8 days of culture in adipocyte 
differentiation medium, the cells were stained with Oil Red-O. b The quantification of a. The Oil-Red O stain was extracted with 100 % isopropanol 
and the optical density at 500 nm (OD500) was determined. c Real-time PCR analyzed PPARγ, aP2 and adiponentin at 8 days after adipogenic medium 
stimulation. The red arrow points to the lipid droplet. Data represent mean ± SEM from three independent experiments. *P < 0.05; **P < 0.01
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Fig. 3 Effect of SIRT1 activation/inhibition on myogenic differentiation and adipogenic differentiation of MSCs. a Schematic representation of the 
experimental design: C3H10T1/2 cells were treated with 20 μM 5-azacytidine for 3 days, then SIRT1 activator (50 μM resveratrol)/inhibitor (10 mM 
nicotinamide) was added to GM of C3H10T1/2 cells for 14 days. b Cells were fixed and stained with Oil Red-O on day 14 days after GM culture. c 
The quantification of b. The Oil-Red O stain was extracted with 100 % isopropanol and the optical density at 500 nm (OD500) was determined. d 
The relative expression profile of adipogenic marker genes: PPARγ, aP2 and adiponentin were determined using Real-time PCR. e PPARγ, aP2 and 
adiponentin protein expression detected by western blotting (left) and densitometry analysis (right) on day 14 days after GM culture. f Cells were 
fixed and stained with Dil on day 14 days after GM culture. g The relative expression profile of myogenic marker genes: MyoD and MyHc were deter-
mined using Real-time PCR. The red arrow points to the lipid droplet. Data represent mean ± SEM from three independent experiments. *P < 0.05; 
**P < 0.01
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Fig. 4 Effect of SIRT1 activation/inhibition on myogenic commitment and adipogenic commitment of MSCs. a Schematic representation of the 
experimental design: 50 μM resveratrol or 10 mM nicotinamide was added to C3H10T1/2 cells with 20 μM 5-AZA during commitment for 3 days, 
then C3H10T1/2 cell was cultured in GM for 14 days. b Cells were fixed and stained with Oil Red-O on day 14 days after GM culture. c The quanti-
fication of b. The Oil-Red O stain was extracted with 100 % isopropanol and the optical density at 500 nm (OD500) was determined. d The relative 
expression profile of adipogenic marker genes: PPARγ, aP2 and adiponentin were determined using Real-time PCR. e PPARγ, aP2 and adiponentin 
protein expression detected by western blotting (left) and densitometry analysis (right) on day 14 days after GM culture. f Cells were fixed and 
stained with Dil on day 14 days after GM culture. g The relative expression profile of myogenic marker genes: MyoD and MyHc were determined 
using Real-time PCR. The red arrow points to the lipid droplet. Data represent mean ± SEM from three independent experiments. *P < 0.05; 
**P < 0.01
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levels of the adipogenic marker genes were significantly 
enhanced in the nicotinamide group (Fig.  4d, e). Taken 
together, our data indicated that activation of SIRT1 by 
resveratrol inhibits C3H10T2/1 adipogenic commit-
ment, whereas inhibition of SIRT1 by nicotinamide pro-
motes C3H10T2/1 adipogenic commitment. Dil staining 
demonstrated results similar to those of differentiation, 
resveratrol enhanced the number of myotubes com-
pared with the control group (Fig.  4f ). The MyoD and 
MyHc mRNA levels were determined via real-time PCR 
(Fig. 4g). The results showed that resveratrol significantly 
increased myogenic commitment and differentiation.
Regulation of Wnt signaling by SIRT1 during MSC 
adipogenic commitment
Using the established model, C3H10T1/2 cells were 
treated with SIRT1 activator/inhibitor during commit-
ment and differentiation. Cells were harvested at 0, 12, 
24, 48 and 72 h of commitment. The mRNA expression 
profile of the Wnt signaling pathway target gene (Cyc-
lin D1) and Wnt antagonists (DACT1 and sFRP2) were 
determined using real-time PCR. The protein expres-
sion profiles of Cyclin D1 and β-catenin, a key compo-
nent of the Wnt signaling pathway, were determined 
through Western blot. The results showed that compared 
with the control group, Cyclin D1 mRNA expression of 
the resveratrol-treated group was significantly higher at 
24  h of commitment, whereas Cyclin D1 expression of 
the nicotinamide-treated group was significantly lower 
than that of the control group at 24  h of commitment. 
Resveratrol promotes the expression of SIRT1, whereas 
nicotinamide inhibits the expression of SIRT1 at 24  h 
of commitment (Fig.  5b). Meanwhile, SIRT1 inhibi-
tion reduces the expression of β-catenin and Cyclin D1 
protein (Fig.  5b). To further investigate whether SIRT1 
mediated Wnt/β-catenin signaling, we used the TCF-
reporter of Wnt/β-catenin signaling. The luciferase assay 
showed that resveratrol increased Wnt/β-catenin signal-
ing (Fig.  5c). RNAi expression of SIRT1 suppressed the 
activity of TCF-reporter (Fig.  5d), whereas overexpres-
sion of SIRT1 significantly increased the luciferase activ-
ity in C3H10T1/2 cells (Fig.  5e). The results indicated 
that SIRT1 controls MSC commitment by relegating Wnt 
signaling. Furthermore, we explore the affects of SIRT1 
on Wnt signaling antagonists. The results showed that 
resveratrol significantly decreased sFRP2 and DACT1 
expression at 24  h, whereas nicotinamide significantly 
increased the expression of sFRP2 and DACT1 dur-
ing commitment (Fig.  5f, g). Furthermore, RNAi SIRT1 
increased the formation of lipid drops, whereas over-
expression SIRT1 reduced the formation of lipid drops 
(Fig.  5h, i). The mRNA expression of PPARγ and adi-
ponectin were similar to the phenotype (Fig.  5j). RNAi 
SIRT1 blocked myogenic differentiation, whereas over-
expression SIRT1 promoted myogenic differentiation of 
C3H10T1/2 cell (Fig.  5k, l). The results suggested that 
during commitment, SIRT1 affects Wnt signaling may via 
regulating Wnt signaling antagonists expression.
Discussion
We established a suitable model for investigating MSC 
commitment and differentiation. Our data suggested that 
SIRT1 is a negative regulator of MSC commitment and 
differentiation to adipocytes. During MSC commitment, 
SIRT1 affects Wnt signaling by regulating Wnt signaling 
antagonists sFRP2 and DACT1 expression and determin-
ing stem cell fate.
Previous research has shown that low concentra-
tions of 5-AZA convert C3H10T1/2 cells into differenti-
ated chondrocytes, adipocytes and skeletal muscle [16]. 
W Wakitani et  al. demonstrated that 5-AZA in culture 
medium induced bone marrow MSCs to differentiate 
into myogenic cells and adipocytes [17]. Treatment with 
5-AZA affected MSC commitment in a dose-dependent 
manner [17], which is consistent with our results. We 
determined that the relatively high concentrations of 
5-AZA treatment (20 and 40  µM) effectively induced 
MSC commitment to the myocyte and adipocyte lineage. 
The relatively lower concentration of 5-AZA (20 µM) was 
used for our study.
SIRT1 has an important function in a wide variety of 
processes, including cell proliferation and differentiation 
[18], apoptosis [19] and metabolism [20]. Picard et al. first 
reported that SIRT1 represses PPARγ by docking with its 
co-factors NCoR and SMRT in 3T3-L1 pre-adipocytes, 
which impairs adipogenic differentiation [12]. Previous 
studies have indicated that SIRT1 has a key modulatory 
role in animal fat metabolism and muscle development 
[21, 22]. In this study, we demonstrated that activation 
of SIRT1 by resveratrol inhibits adipogenic differentia-
tion, whereas inhibition of SIRT1 by nicotinamide pro-
motes adipogenic differentiation in an established model 
of MSCs induced by 5-AZA (Fig. 3), consistent with pre-
vious study. Resveratrol inhibits human pre-adipocyte 
proliferation and adipogenic differentiation in an SIRT1-
dependent manner [23]. Conversely, nicotinamide sig-
nificantly induces the differentiation of pre-adipocyte 
into adipocyte [24]. In addition, studies have suggested 
that SIRT1 promotes osteogenesis and decreases adipo-
genesis of MSCs [25–27]. Resveratrol/nicotinamide was 
added to C3H10T1/2 cells with 5-AZA during commit-
ment. Notably, our data showed that resveratrol inhib-
its adipogenic commitment and differentiation and 
promotes myogenic differentiation (Fig.  4). By contrast, 
nicotinamide promotes adipogenic commitment and dif-
ferentiation (Fig. 4). Activation of SIRT1 by consistently 
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Fig. 5 Effect of SIRT1 activation/inhibition on Wnt signaling pathways during commitment of MSCs. 50 μM resveratrol or 10 mM nicotinamide was 
added to C3H10T1/2 cells with 20 μM 5-AZA during commitment for 3 days. a The relative expression profiles of CyclinD1 mRNA was determined 
using Realtime-PCR. b SIRT1, β-catenin and Cyclin D1 protein expression detected by western blotting at 24 h. c The luciferase reporter activity was 
measured at 24 h after transfection with resveratrol or nicotinamide. d RNAi SIRT1 plasmid was co-transfected into C3H10T1/2 cells with TCF-recep-
tor. e Overexpression SIRT1 plasmid was co-transfected into C3H10T1/2 cells with TCF-receptor. The luciferase reporter activity was measured 48 h 
after transfection. f sFRP2 mRNA measured by Realtime-PCR and g Dact1 mRNA measured by Realtime-PCR at 0, 12, 24, 48, and 72 h. h Cells were 
fixed and stained with Oil Red-O on day 14 days after GM culture. i The quantification of h. The Oil-Red O stain was extracted with 100 % isopro-
panol and the optical density at 500 nm (OD500) was determined. j The relative expression profile of adipogenic marker genes: PPARγ, adiponentin 
were determined using Real-time PCR. k Cells were fixed and stained with Dil on day 14 days after GM culture. l The relative expression profile of 
myogenic marker genes: MyoD and MyHc were determined using Real-time PCR. Data represent mean ± SEM from three independent experi-
ments. *P < 0.05; **P < 0.01
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adding resveratrol blocked adipocyte development 
and increased the expression of osteoblast markers in 
C3H10T1/2 [1]. However, this finding did not justify 
the role of SIRT1 during commitment of MSCs. Simi-
larly, activation of SIRT1 activity with resveratrol for the 
duration increased muscle precursor cell proliferation, 
whereas inhibition of SIRT1 with nicotinamide lowered 
proliferation [27, 28]. Our finding provides further evi-
dence that SIRT1 is a negative regulator of MSC differ-
entiation to adipocyte. More interestingly, similar to the 
differentiation stage, SIRT1 suppresses adipocyte lineage 
commitment of MSCs.
Wnt signaling pathways have important functions in 
controlling the fate of MSCs [4]. Wnt/β-catenin signaling 
promotes the differentiation of MSCs into myocytes and 
osteocytes and suppresses commitment to the adipocyte 
lineage [4]. However, the molecular mechanism of SIRT1 
regulation by Wnt signaling is unclear. Our study dem-
onstrated that resveratrol treatment led to an increased 
mRNA level of Cyclin D1, a well-known Wnt signal-
ing target gene. In addition, resveratrol treatment more 
significantly increased β-catenin and Cyclin D1 pro-
tein expression compared with nicotinamide treatment 
(Fig.  5). Inhibition SIRT1 reduced the activity of TCF-
reporter, whereas activation SIRT1 significantly increased 
the luciferase activity in C3H10T1/2 cells (Fig. 5). Zhou 
et al. showed that resveratrol treatment was significantly 
higher in cells transfected with TOPFlash reporter vec-
tor than in cells transfected with the negative control 
FOPFlash reporter vector [29]. In addition, their results 
suggested that an increase in the level of β-catenin in 
response to resveratrol is mediated by a downregulation 
of the kinase activity of GSK-3β [29]. However, SIRT1 
can deacetylate histones and a number of non-histone 
substrates. Researchers have proposed that SIRT1 can 
regulate the Wnt signaling pathway through other means. 
Simic et al. showed that SIRT1 deacetylates β-catenin to 
promote its accumulation in the nucleus leading to tran-
scription of genes for MSC differentiation [30]. sFRPs are 
extracellular Wnt signaling antagonists that directly bind 
Wnt molecules and sequester them from their mem-
brane-bound receptors [2]. Park et  al. found that sFRP 
levels increased gradually during adipogenesis via inhibi-
tion of Wnt signaling in human amniotic MSCs [31]. Our 
study suggested that resveratrol treatment significantly 
increased the mRNA level of sFRP2, whereas nicotina-
mide treatment significantly suppressed the mRNA level 
of sFRP2 in the early stages of commitment of MSCs. 
SIRT1 localises to the promoter of sFRP2, directly con-
tributing to the aberrant epigenetic silencing of breast 
cancer cells [32, 33]. Dacts are intracellular mediators of 
Wnt signaling that interact with the protein Dishevelled, 
thereby inhibiting conduction of the signal from the Fz/
LRP receptor complex [2]. Our study suggested that res-
veratrol treatment significantly increased the mRNA 
level of Dact1, whereas nicotinamide treatment signifi-
cantly suppressed the mRNA level of Dact1 in the early 
stages of commitment of MSCs. Previous studies have 
shown that Dact1 regulates adipogenesis through coor-
dinated effects on gene expression that selectively alter 
intracellular and paracrine/autocrine components of the 
Wnt/β-catenin signaling pathway [8]. Together with our 
findings, these data suggest that SIRT1 may block adipo-
genesis of MSCs by inhibiting the expression of the Wnt 
signaling antagonists sFRP2 and DACT1. Future studies 
will focus on the molecular mechanisms through which 
SIRT1 regulates Wnt signaling during adipogenesis of 
MSCs.
In conclusion, although further studies are required to 
elucidate the molecular mechanisms underlying SIRT1-
mediated adipogenesis and myogenic differentiation 
of MSCs, these results clearly identify SIRT1 as a nega-
tive regulator of MSC commitment and differentiation 
to adipocyte, and as a positive regulator for myogenic 
differentiation in MSCs. SIRT1 may affect MSC fate by 
regulating Wnt signaling pathway. These findings further 
confirmed that SIRT1 may potentially have a role in the 
development of obesity-related diseases.
Methods
Cell culture
C3H10T1/2 cell was purchased from Cell Bank of Type 
Culture Collection of China Science Academy (Shang-
hai, China) and grown in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10 % fetal bovine 
serum (FBS) (Gibco BRL) in a 5 % CO2 incubator at 37 °C. 
To induce adipocyte lineage commitment, C3H10T1/2 
stem cells were plated at low density of 40–50  % and 
cultured in DMEM containing 10  % calf serum with 
5-AZA (A3656, St. Louis, MO, USA). After the cells 
reached postconfluence, they were maintained by using 
the growth medium (GM). For adipocyte differentiation 
assay, cells were induced with a cocktail of dexametha-
sone (1  μM), insulin (10  μg/ml), isobutylmethyxanthine 
(0.5  mM) (DMI) and 10  % FBS. 2  days after induction, 
cells were maintained in DMEM containing insulin 
(10  μg/ml) for an additional 2  days and 10  % FBS until 
they were ready for harvest [34].
DiI staining and Oil red‑O staining
After treatment with GM for 14d, C3H10T1/2 cells 
were stained with the membrane probe DiI (Beyotime, 
Haimen, China) at 37  °C for 5–10  min, fixed with 4  % 
paraformaldehyde for 15 min. The cells were mounted in 
mounting reagent (DTT/PBS/glycerol). Accumulation of 
triglyceride content in differentiated cells was visualized 
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by staining with Oil red-O (Sigma-Aldrich). Cells were 
washed twice with PBS and fixed with 10  % formalde-
hyde for 45 min at room temperature. After washing with 
distilled water twice and 50 % isopropanol once, the cells 
were stained for 1 h at room temperature with filtered Oil 
red O/60 % isopropanol solution. The cells were washed 
twice with distilled water and twice with PBS. Adipocytes 
stained red were recorded by light microscopy (Leica 
German). To quantify staining, Oil Red O was extracted 
from the cells with 100  % isopropanol, and the optical 
density was measured at 500 nm (OD500).
Real‑time quantitative PCR
Total RNA was isolated from cells using Trizol reagent 
following the protocol provided by the manufacturer (Inv-
itrogen) and reverse transcribed according to the manu-
facturer’s protocol (Takara, Dalian, China). Real-time 
PCR was performed by mixing cDNA with primers, and 
iTaq™ Universal SYBR® Green Supermix quantitative 
PCR analysis reactions (Bio-Rad, USA). Real-time PCR 
was performed using a LightCycler® 480 System with 
supplied software (Roche, USA), according to the manu-
facturer’s instructions. RNA expression levels were com-
pared after normalization to endogenous β-actin. The 
primer sequences used in this study are listed in Table 1.
Western blotting
Western blotting was performed as previously 
described. Whole-cell protein lysates were extracted 
with a solution containing 20  mM Tris–HCl (pH 7.5), 
150  mM NaCl, 1  % Triton X-100, 10  mM Na4P2O7, 
1  mM Na3VO4, 2  mM EDTA, 0.5  mM leupeptin, and 
1 mM PMSF (Beyotime, China). The protein concentra-
tions were determined using a Bradford Protein Assay 
Kit (Beyotime, China), and proteins were separated 
by 10  % SDS-PAGE. The separated proteins were then 
transferred to polyvinylidene difluoride (PVDF) mem-
branes (Bio-Rad, USA). Membrane blocking to prevent 
nonspecific binding was done with TTBS buffer [10 mM 
Tris–HCl (pH 7.6), 150 mM NaCl, 0.1 % Tween 20] con-
taining 5 % skim milk powder. The blocked membranes 
were then incubated with a mouse specific anti-SIRT1 
antibody (number 2028; Cell Signaling Technology Inc, 
Danvers, MA, USA), or a rabbit polyclonal anti-PPARγ 
(number sc-1984; Santa Cruz), or a rabbit polyclonal 
anti-FABP4 (number 2120; Cell Signaling Technology 
Inc.), or a rabbit monoclonal anti-adiponectin (num-
ber 2789; Cell Signaling Technology Inc.), α-Tubulin 
(number sc-53646; Santa Cruz), and β-actin (number 
3700; Cell Signaling Technology Inc.) for overnight at 
4  °C. Secondary antibodies were used according to the 
manufacturer’s instructions. Secondary-antibody bind-
ing was detected using an enhanced chemiluminescence 
detection kit (Thermo Fisher Scientific, USA) according 
to the manufacturer’s instructions. Protein levels were 
normalized to β-actin using Image J analysis software.
Transient transfection assays
For transient transfection assays, C3H10T1/2 cells were 
seeded to 24-well plate at 5 × 104 cells/well 24 h before 
Table 1 Primer sequences in this study
Gene Primers (sense/antisense 5′–3′ Product length (bp) Ta (°C)
MyoD CGCTCCAACTGCTCTGATGGCAT 280 61
GGGTTCCCTGTTCTGTGTCGCTT
MyHc TCGGGGTCTTGGACATTGCTGG 342 61
CTTTGGCGGGTTTGGGCTTCTG
PPARγ TGGGTGAAACTCTGGGAGATTC 250 60
AGAGGTCCACAGAGCTGATTCC
aP2 GTGTGATGCCTTTGTGGGAAC 235 60
CCTGTCGTCTGCGGTGATT
adiponentin GCTCTCCTGTTCCTCTTAATCCT 437 60
CCAGTGCTGCCGTCATAATG
Cyclin D1 AAATGCCAGAGGCGGATGAG 200 60
AAGAAAGTGCGTTGTGCGGT
sFRP2 AATCGGCATCTAAGTCTT 129 56
GCAATGAGGAATGGTTAC
DACT1 TCTGAGGAATGGAAGTGTG 169 58
GTCTGTCTTTGAGTCTTTGG
β-actin GGCACCACACCTTCTACAATG 133 60
GGGGTGTTGAAGGTCTCAAAC
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transfection. The cells were transiently transfected with 
plasmids at 80  % confluence using Lipofectamine 2000 
reagent (Invitrogen) according to the manufacturer’s 
instructions. The DNA/reagent ratio was 1 μg/2 μL. After 
24 h transfection, the cells were harvested for subsequent 
analysis. The RNA interfering (RNAi) plasmid pSIREN-
RetroQ-ZsGreen (pSIREN-SIRT1) (siSIRT1) 5′-GAT-
GAAGTTGACCTCCTCA-3′, synthesized according to 
the literature (Picard et al. [12]). pCDNA 3.1-SIRT1 plas-
mid was kindly provided from Dr. Zhai (Chinese Acad-
emy of Sciences).
Luciferase reporter assay
The TOPflash plasmid (Millipore) was used to monitor 
the Wnt/β-catenin signaling. The TOP/FOP Flash assays 
were performed according to the manufacturer’s instruc-
tions. The cells were treated as indicated, and luciferase 
activity was measured with the Dual-Luciferase reporter 
assay system (Promega).
Statistical analyses
Results are presented as the means  ±  standard errors. 
Statistical analysis was performed with SAS. Version 
8 (SAS Inc., Chicago, IL, USA). Data were analyzed by 
Duncan’s multiple-range test was performed if differ-
ences were identified among the groups at P < 0.05.
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